<DOC>
	<DOC>NCT01078233</DOC>
	<brief_summary>The main objective of the study is to monitor health outcomes associated with antiretroviral drugs in a population of HIV-infected patients.</brief_summary>
	<brief_title>Observational Data Analysis in EuroSIDA (MK-0518-058)</brief_title>
	<detailed_description>Time Perspective: Retrospective and Prospective</detailed_description>
	<mesh_term>Raltegravir Potassium</mesh_term>
	<criteria>Adults 16 years old and older with HIV1 Subjects will be excluded if they have no prospective follow up</criteria>
	<gender>All</gender>
	<minimum_age>16 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>HIV</keyword>
	<keyword>antiretroviral treatment</keyword>
	<keyword>HIV Cohort</keyword>
	<keyword>Treatment</keyword>
</DOC>